Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan;40(1):125-128.
doi: 10.2337/cd21-0035.

Worsening of Glycemic Control in a Patient With Fulminant Type 1 Diabetes Receiving Sensor-Augmented Pump Therapy: A Case of Extensive Localized Lipoatrophy Requiring Attention in Relation to Cannula Insertion Sites

Keiko Koide  1 , Koichiro Azuma  2 , Yoshihito Atsumi  1
Affiliations
Case Reports

Worsening of Glycemic Control in a Patient With Fulminant Type 1 Diabetes Receiving Sensor-Augmented Pump Therapy: A Case of Extensive Localized Lipoatrophy Requiring Attention in Relation to Cannula Insertion Sites

Keiko Koide et al. Clin Diabetes. 2022 Jan.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Extensive lipoatrophy localized mainly in the right abdomen.
FIGURE 2
FIGURE 2
CT image of localized lipoatrophy in the right abdomen.
FIGURE 3
FIGURE 3
A trend toward improvement in LL seen with the use of cannula insertion sites in rotation.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Imagawa A, Hanafusa T. Fulminant type 1 diabetes: an important subtype in East Asia. Diabetes Metab Res Rev 2011;27:959–964 - PubMed
    1. Radermecker RP, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol 2007;8:21–28 - PubMed
    1. Holstein A, Stege H, Kovacs P. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf 2010;9:225–231 - PubMed
    1. Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB. Human insulin analog-induced lipoatrophy. Diabetes Care 2008;31:442–444 - PubMed
    1. Sackey AH. Images in clinical medicine: injection-site lipoatrophy. N Engl J Med 2009;361:e41. - PubMed

Publication types